PCN Insights, News, Videos, and More

Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses recent guidelines on identifying and treating tardive dyskinesia.

Bipolar Disorders Section Editor Joseph F. Goldberg, MD, explains some key distinctions between bipolar I disorder and bipolar II disorder and treatment implications of the differences. 

Karen Scott, MD, MPH, President of the Foundation for Opioid Response Efforts, outlines barriers people face to receiving treatment for opioid use disorder, populations least likely to receive care for the disorder, and successful strategies...

Vladimir Maletic, MD, MS, and Greg Mattingly, MD, discuss recent research on the use of medications for attention-deficit/hyperactivity disorder in patients with comorbidities such as anxiety disorders, mood disorders, and tic disorders.

A session being presented at the virtual 2021 American Psychiatric Association Annual Meeting will explore equity and ethical issues related to the practice and examine the future of telemedicine, including an array of digital tools.

BLOG: How much energy will it take to overcome the inertia that has befallen our daily lives? Will we reenact a simulacrum of how things were before, or will we find, deep within ourselves, the capacity for reimagination of what could be?

Andrew Penn, RN, MS, NP, CNS, APRN-BC, founding member of the Organization of Psychedelic and Entheogenic Nurses (OPENurses) and a Sana Symposium steering committee member, discusses psychedelics that mental health professionals should be...

Christoph U. Correll, MD, explains the importance of medication adherence in patients taking antipsychotics, how long-acting injectables (LAIs) improve adherence, and strategies for educating patients on LAIs.